• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

If Biogen was considered a good company - It no longer is and hasn't been for a very long time

anonymous

Guest
The leadership has pounded this company into the ground. It is one of the worst companies in the industry and they treat their employees like garbage. Walk the halls and speak with veterans and it is always the same "This is not the Biogen I knew or respected."

Absolutely no reason in the world to stay here. No job is worth sacrifices to your health and self-respect.
 












New training on the way. Please add any new badges you earn to your Linkedin trophy case of Emasculating Male Toxicity, Compensating for White Guilt, and Self Care Black Belt badges.

Wokism as intellectual wealth.
Doing better science with DEI.
The 56k moral.
Executive nobility.
The ethics of receiving money for selling hope.
The intrinsic value of the executive

2022 training curriculums coming soon. Sign up now as spaces will fill fast.
 




Now sub $200 stock and sub 30B company.

They can give you more in rsus, but experience should also tell you that the leadership will somehow drag down the overall value by the time they vest.

Somehow, more becomes less.

But Michel just needs luck to turn. No ownership and no catalysts that end the dumpster fire.
 




New training on the way. Please add any new badges you earn to your Linkedin trophy case of Emasculating Male Toxicity, Compensating for White Guilt, and Self Care Black Belt badges.

Wokism as intellectual wealth.
Doing better science with DEI.
The 56k moral.
Executive nobility.
The ethics of receiving money for selling hope.
The intrinsic value of the executive

2022 training curriculums coming soon. Sign up now as spaces will fill fast.

LMAO
 




How is Michel still employed?

Does anyone on the board even have a pulse? Cause this ship has been sinking for years with the lt and decisions they sanction. And no it isnt bad luck or surprising as it was fairly obvious to many. Even if you believed in Aduhelm, going all in on it was always going to be a disaster.

And the clinical trial should stay. Biogen failed the phase 3 that it designed. Then tried to soak medicare as the majority payer. Now somehow is spinning DEI access narratives as overriding marginal if not failed science. Shameful. No other major market in the world is going to approve Aduhoax and that should be indicative.

FDA made a huge error in approving this. CMS hopefully does what it can. Fake theater and fictional blockbuster potential nonsense needs to stop. Oh but Michel is entitled to being paid for failing on aduhell and his job for that matter.

Tick tock. Time to end the endless fiction.
 




How is Michel still employed?

Does anyone on the board even have a pulse? Cause this ship has been sinking for years with the lt and decisions they sanction. And no it isnt bad luck or surprising as it was fairly obvious to many. Even if you believed in Aduhelm, going all in on it was always going to be a disaster.

And the clinical trial should stay. Biogen failed the phase 3 that it designed. Then tried to soak medicare as the majority payer. Now somehow is spinning DEI access narratives as overriding marginal if not failed science. Shameful. No other major market in the world is going to approve Aduhoax and that should be indicative.

FDA made a huge error in approving this. CMS hopefully does what it can. Fake theater and fictional blockbuster potential nonsense needs to stop. Oh but Michel is entitled to being paid for failing on aduhell and his job for that matter.

Tick tock. Time to end the endless fiction.

Michel (say it in your best Eurotrash accent) must have pictures of all the board members in flagrante delicto with farm animals. There’s no other explanation.

Biogen has truly become the pariah and laughingstock of the pharma industry - unethical, inept, incompetent, pathologically politically correct, tone-deaf and completely unconcerned about patient welfare and wellbeing.
 




How is Michel still employed?

Does anyone on the board even have a pulse? Cause this ship has been sinking for years with the lt and decisions they sanction. And no it isnt bad luck or surprising as it was fairly obvious to many. Even if you believed in Aduhelm, going all in on it was always going to be a disaster.

And the clinical trial should stay. Biogen failed the phase 3 that it designed. Then tried to soak medicare as the majority payer. Now somehow is spinning DEI access narratives as overriding marginal if not failed science. Shameful. No other major market in the world is going to approve Aduhoax and that should be indicative.

FDA made a huge error in approving this. CMS hopefully does what it can. Fake theater and fictional blockbuster potential nonsense needs to stop. Oh but Michel is entitled to being paid for failing on aduhell and his job for that matter.

Tick tock. Time to end the endless fiction.

Board is more to blame than Michel. They made a strong case to the board after he was brought on board that Biogen should do a major deal while cash flows were strong from MS. Board said no. And who the hell signed off on selling off Ocrvus and Hemophilia when George was here? What a stupid decision.

How's that bet it all on Aduhelm working out?